Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1985 1
1986 1
2007 1
2008 1
2011 2
2012 1
2013 1
2014 1
2017 1
2019 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

11 results
Results by year
Filters applied: . Clear all
Page 1
Avelumab in patients with previously treated metastatic melanoma: phase 1b results from the JAVELIN Solid Tumor trial.
Keilholz U, Mehnert JM, Bauer S, Bourgeois H, Patel MR, Gravenor D, Nemunaitis JJ, Taylor MH, Wyrwicz L, Lee KW, Kasturi V, Chin K, von Heydebreck A, Gulley JL. Keilholz U, et al. Among authors: gravenor d. J Immunother Cancer. 2019 Jan 16;7(1):12. doi: 10.1186/s40425-018-0459-y. J Immunother Cancer. 2019. PMID: 30651126 Free PMC article. Clinical Trial.
Tricyclic antidepressant agranulocytosis.
Gravenor DS, Leclerc JR, Blake G. Gravenor DS, et al. Can J Psychiatry. 1986 Oct;31(7):661. doi: 10.1177/070674378603100712. Can J Psychiatry. 1986. PMID: 3779595
TITAN: phase III study of doxorubicin/cyclophosphamide followed by ixabepilone or paclitaxel in early-stage triple-negative breast cancer.
Yardley DA, Arrowsmith ER, Daniel BR, Eakle J, Brufsky A, Drosick DR, Kudrik F, Bosserman LD, Keaton MR, Goble SA, Bubis JA, Priego VM, Pendergrass K, Manalo Y, Bury M, Gravenor DS, Rodriguez GI, Inhorn RC, Young RR, Harwin WN, Silver C, Hainsworth JD, Burris HA 3rd. Yardley DA, et al. Among authors: gravenor ds. Breast Cancer Res Treat. 2017 Aug;164(3):649-658. doi: 10.1007/s10549-017-4285-6. Epub 2017 May 15. Breast Cancer Res Treat. 2017. PMID: 28508185 Clinical Trial.
A retrospective study to evaluate the work-up and follow-up of patients with monoclonal gammopathy of undetermined significance.
Berenson JR, Yellin O, Quiery A, Brady J, Patel R, Wong SF, Colbourn D, Gravenor D, Tiffany N, Shamasunder HK, Waterman B, Melamed K, Wirtschafter E. Berenson JR, et al. Among authors: gravenor d. Clin Lymphoma Myeloma Leuk. 2011 Aug;11(4):336-41. doi: 10.1016/j.clml.2011.02.002. Epub 2011 May 6. Clin Lymphoma Myeloma Leuk. 2011. PMID: 21816371
Prognostic factors and jaw and renal complications among multiple myeloma patients treated with zoledronic acid.
Berenson JR, Yellin O, Crowley J, Makary A, Gravenor DS, Yang HH, Upadhyaya GH, Flinn IW, Staszewski H, Tiffany NM, Sanani S, Farber CM, Morganstein N, Bolejack V, Nassir Y, Hilger JD, Sefaradi A, Shamouelian A, Swift RA. Berenson JR, et al. Among authors: gravenor ds. Am J Hematol. 2011 Jan;86(1):25-30. doi: 10.1002/ajh.21912. Am J Hematol. 2011. PMID: 21120861 Free article.
Phase I/II trial assessing bendamustine plus bortezomib combination therapy for the treatment of patients with relapsed or refractory multiple myeloma.
Berenson JR, Yellin O, Bessudo A, Boccia RV, Noga SJ, Gravenor DS, Patel-Donnelly D, Siegel RS, Kewalramani T, Gorak EJ, Nassir Y, Swift RA, Mayo D. Berenson JR, et al. Among authors: gravenor ds. Br J Haematol. 2013 Feb;160(3):321-30. doi: 10.1111/bjh.12129. Epub 2012 Nov 15. Br J Haematol. 2013. PMID: 23150919 Clinical Trial.
Randomized phase II trial of a toll-like receptor 9 agonist oligodeoxynucleotide, PF-3512676, in combination with first-line taxane plus platinum chemotherapy for advanced-stage non-small-cell lung cancer.
Manegold C, Gravenor D, Woytowitz D, Mezger J, Hirsh V, Albert G, Al-Adhami M, Readett D, Krieg AM, Leichman CG. Manegold C, et al. Among authors: gravenor d. J Clin Oncol. 2008 Aug 20;26(24):3979-86. doi: 10.1200/JCO.2007.12.5807. J Clin Oncol. 2008. PMID: 18711188 Clinical Trial.
11 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page